WEAV logo

Weave Communications Inc. (WEAV)

$5.15

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on WEAV

Market cap

$409763020

EPS

-0.32

P/E ratio

--

Price to sales

1.66

Dividend yield

--

Beta

1.632038

Price on WEAV

Previous close

$5.19

Today's open

$5.18

Day's range

$5.02 - $5.28

52 week range

$4.24 - $11.32

Profile about WEAV

CEO

Brett White

Employees

854

Headquarters

Lehi, UT

Exchange

New York Stock Exchange

Shares outstanding

79565635

Issue type

Common Stock

WEAV industries and sectors

Healthcare

Healthcare Providers & Services

News on WEAV

Weave Communications, Inc. (WEAV) Q1 2026 Earnings Call Transcript

Weave Communications, Inc. (WEAV) Q1 2026 Earnings Call Transcript

news source

Seeking Alpha • May 1, 2026

news preview

Weave Announces First Quarter 2026 Financial Results

LEHI, Utah--(BUSINESS WIRE)--Weave Communications, Inc. (“Weave”) (NYSE: WEAV), a leading vertical SaaS platform that delivers AI-powered patient engagement and payment solutions for small and medium-sized healthcare practices, today announced its financial results for the first quarter ended March 31, 2026. "Weave delivered another excellent quarter, with revenue growth accelerating to 17.4% year-over-year and the most customer location additions in a single quarter in our history. We also dro.

news source

Business Wire • Apr 30, 2026

news preview

Weave Communications, Inc. (WEAV) Q1 Earnings and Revenues Beat Estimates

Weave Communications, Inc. (WEAV) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.01 per share a year ago.

news source

Zacks Investment Research • Apr 30, 2026

news preview

Weave Bio Launches NDA Workflow Designed in Partnership with Parexel; Extending AI-Native Platform Coverage Across the Full Regulatory Lifecycle

SAN FRANCISCO & RALEIGH, N.C.--(BUSINESS WIRE)-- #Biotech--Weave Bio, the leader in AI-native regulatory automation for drug development, and strategic partner Parexel, a leading global clinical development partner, today announced that the Weave platform now supports New Drug Application (NDA) submissions, advancing the company's coverage of the full regulatory lifecycle. Parexel brings more than 40 years of regulatory experience and a track record of successful NDA submissions to the partnership. Throug.

news source

Business Wire • Apr 29, 2026

news preview

Weave Call Intelligence Helps Address Rising Care Deferral as Patients Delay Procedures Over Concerns About Affordability

LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient communications and engagement platform purpose-built for healthcare practices, today announced a series of platform enhancements to one of its leading AI products, Call Intelligence. The latest updates turn the product from a robust analytics tool into a deeply embedded, AI-driven workflow engine for modern healthcare practices. The announcement comes at a pivotal moment for the healthcare industry. According to recen.

news source

Business Wire • Apr 22, 2026

news preview

Weave's Latest Platform Enhancements Power Smarter Growth for Healthcare Practices

LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient communications and engagement platform purpose-built for healthcare practices, highlights the release of comprehensive platform enhancements designed to help practices capture more patient demand, streamline day-to-day operations, and deliver personalized experiences at scale. “Healthcare practices require solutions designed around long-term patient relationships and complex workflows,” said Brett White, Chief Executi.

news source

Business Wire • Apr 17, 2026

news preview

Weave to Announce First Quarter 2026 Financial Results on April 30, 2026

LEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading AI-powered patient communications and engagement platform purpose-built for healthcare practices, today announced it will release its financial results for the first quarter of 2026 after U.S. markets close on Thursday, April 30, 2026. Company management will host a live audio webcast at 4:30 p.m. ET to discuss Weave's financial results and provide a business update. The live audio webcast will be available on the Weave Investor Relatio.

news source

Business Wire • Apr 16, 2026

news preview

The Fiber Weave Skew Problem Is Over: ACCM Celeritas™ SF1600 Delivers Zero-Skew for PCIe 7, 224 Gbps and Beyond

SAN JOSE, Calif.--(BUSINESS WIRE)--Advanced Chip & Circuit Materials, Inc. (ACCM) today introduced Celeritas SF1600, a laminate and prepreg material that eliminates fiber weave skew at its root. Fiber weave skew is a materials problem, not a routing one. Woven glass creates a spatially periodic dielectric in which differential pairs travel alternately through resin-rich and glass-rich regions. In a differential pair, the two conductors traverse different paths, which produces a time delay (.

news source

Business Wire • Apr 3, 2026

news preview

Weave Communications Appoints Edward Robson and Ryan Dubin to Board of Directors

LEHI, Utah--(BUSINESS WIRE)--Weave Communications, Inc. (NYSE: WEAV) (“Weave” or the “Company”), a leading vertical SaaS platform that delivers AI-powered patient engagement and payment solutions for small and medium-sized healthcare practices, today announced the appointment of two new independent directors, Ryan Dubin and Edward Robson, to its Board of Directors (the “Board”), effective immediately. These appointments were made in connection with a cooperation agreement with Engine Capital, L.

news source

Business Wire • Mar 30, 2026

news preview

Minted Technology Advisors Unlocks Growth for Healthcare Practices Through Weave Partnership

LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient communications and engagement platform purpose-built for small and medium-sized healthcare practices, today recognized its partnership with Minted Technology Advisors, whose MintedCX advisory model helps healthcare practices adopt modern patient communication and engagement technology. Through its MintedCX initiative, Minted Technology Advisors works with healthcare organizations to improve patient experience, team ef.

news source

Business Wire • Mar 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Weave Communications Inc.

Open an M1 investment account to buy and sell Weave Communications Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in WEAV on M1